Skip to content

Chiara Maniaci


Chiara obtained her MSci in Pharmaceutical chemistry and technology at the University of Messina in 2013. Her research project concerned the development of novel iron chelators as potential drugs for the treatment of Parkinson’s disease under the joint supervision of Prof. Robert Hider at KCL and Prof. Giovanni Romeo at University of Messina. In 2014 Chiara joined Prof. Alessio Ciulli and Prof. Dario Alessi labs at University of Dundee to conduct her PhD project on the development of Homo-PROTAC bivalent small-molecule dimerizers to induce self-degradation of the VHL E3 ubiquitin ligase. Following award of her PhD in Chemical Sciences in 2017, and postdoctoral research in Dundee, Chiara joined the Kawamura group in Oxford in January 2018 to acquire knowledge and experience in molecular mechanisms of epigenetic processes.